These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 7972851)

  • 1. Cost-effectiveness analysis in heart disease, Part I: General principles.
    Kupersmith J; Holmes-Rovner M; Hogan A; Rovner D; Gardiner J
    Prog Cardiovasc Dis; 1994; 37(3):161-84. PubMed ID: 7972851
    [No Abstract]   [Full Text] [Related]  

  • 2. Cost-effectiveness ratios: in a league of their own.
    Birch S; Gafni A
    Health Policy; 1994 May; 28(2):133-41. PubMed ID: 10136058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the decision rules of cost-effectiveness analysis.
    Johannesson M; Weinstein MC
    J Health Econ; 1993 Dec; 12(4):459-67. PubMed ID: 10131756
    [No Abstract]   [Full Text] [Related]  

  • 4. The future of health economic modeling: have we gone too far or not far enough?
    Fendrick AM
    Value Health; 2006; 9(3):179-80. PubMed ID: 16689711
    [No Abstract]   [Full Text] [Related]  

  • 5. Bringing health economic modeling to the 21st century.
    Eddy D
    Value Health; 2006; 9(3):168-78. PubMed ID: 16689710
    [No Abstract]   [Full Text] [Related]  

  • 6. Cost effectiveness/utility analyses. Do current decision rules lead us to where we want to be?
    Birch S; Gafni A
    J Health Econ; 1992 Oct; 11(3):279-96. PubMed ID: 10122540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implications of basing health-care resource allocations on cost-utility analysis in the presence of externalities.
    Labelle RJ; Hurley JE
    J Health Econ; 1992 Oct; 11(3):259-77. PubMed ID: 10122539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic analysis in dermatology.
    Ellis CN; Reiter KL; Wheeler JR; Fendrick AM
    J Am Acad Dermatol; 2002 Feb; 46(2):271-83. PubMed ID: 11807441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-Effectiveness of a Home Based Intervention for Secondary Prevention of Readmission with Chronic Heart Disease.
    Byrnes J; Carrington M; Chan YK; Pollicino C; Dubrowin N; Stewart S; Scuffham PA
    PLoS One; 2015; 10(12):e0144545. PubMed ID: 26657844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic considerations for the hepatologist.
    Provenzale D
    Hepatology; 1999 Jun; 29(6 Suppl):13S-17S. PubMed ID: 10386077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cost-effectiveness analysis of amniocentesis and chorionic villus sampling for prenatal genetic testing.
    Heckerling PS; Verp MS
    Med Care; 1994 Aug; 32(8):863-80. PubMed ID: 8057700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decision analysis: balancing quality and cost.
    Brasel KJ; Weigelt JA
    Infect Control Hosp Epidemiol; 1997 Feb; 18(2):146-8. PubMed ID: 9120246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac care for infants. Determinants of hospital charges for acute care.
    Pearson GD; Kidd L; Beittel TM; Neill CA
    Am J Dis Child; 1991 Dec; 145(12):1397-400. PubMed ID: 1669668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome measurement in economic evaluation.
    Johannesson M; Jönsson B; Karlsson G
    Health Econ; 1996; 5(4):279-96. PubMed ID: 8880165
    [No Abstract]   [Full Text] [Related]  

  • 15. Modelling programme costs in economic evaluation.
    Fenn P; McGuire A; Backhouse M; Jones D
    J Health Econ; 1996 Feb; 15(1):115-25. PubMed ID: 10157425
    [No Abstract]   [Full Text] [Related]  

  • 16. A bootstrap approach to medical decision analysis.
    Mennemeyer ST; Cyr LP
    J Health Econ; 1997 Dec; 16(6):741-7. PubMed ID: 10176782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The "Intervention Index": insufficient information.
    Kottke TE
    J Clin Epidemiol; 1992 Jan; 45(1):17-9. PubMed ID: 1738007
    [No Abstract]   [Full Text] [Related]  

  • 18. The economics of heart transplantation.
    Evans RW
    Circulation; 1987 Jan; 75(1):63-76. PubMed ID: 3098447
    [No Abstract]   [Full Text] [Related]  

  • 19. Health care reform and belt tightening: how can we become more cost effective? Commentary.
    Garson A
    Curr Opin Cardiol; 1995 Jan; 10(1):29-32. PubMed ID: 7787261
    [No Abstract]   [Full Text] [Related]  

  • 20. Quality-adjusted life years: origins, measurements, applications, objections.
    Schwartz S; Richardson J; Glasziou PP
    Aust J Public Health; 1993 Sep; 17(3):272-8. PubMed ID: 8286504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.